slides · global inventory
Chart
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 78,129
Current window 22,081-22,110
Pages 2,605
Rows per page 30
Component
22,081-22,110 of 78,129
32
Uses a before-after framing to contrast industry benchmarks with Absci's performance metrics.Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations 2 hits
68
The slide uses a process flow diagram to explain the technical workflow of the company's core technology.Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations 2 hits
79
The slide outlines a proprietary workflow combining AI-driven design with experimental validation.Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations 2 hits
81
The slide uses a dot plot to show binding affinity vs sequence diversity and a bar chart to compare binding rates.Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations 2 hits
82
The slide shows two dose-response curves (Cell Surface Binding and ADCC) and two molecular surface models for epitope mapping.Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations 2 hits
88
The slide uses a process flow (1 -> 2) followed by a scatter plot validation and a summary table of Pearson R values.Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations 2 hits
10
The slide uses a structural biology visualization and two dose-response curves to establish bio-equivalence and differentiation.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Spyre Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle2 hits
11
The slide uses two semi-logarithmic line charts to compare drug concentration decay over time.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Spyre Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle2 hits
14
The slide uses a comparative bar chart approach to justify the human half-life prediction based on NHP data.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Spyre Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle2 hits
16
The slide uses a combination of a pharmacokinetic simulation line chart and a bar chart showing clinical remission rates by exposure quartile.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Spyre Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle2 hits
23
The slide uses two distinct chart types to demonstrate potency (dose-response curve) and diversity (scatter plot of IC50 vs Relative DcR3/DR3 Blocking).Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Spyre Therapeutics
Pitch deck Investor relations 2 hits
10
Includes structural biology visualization, dose-response curves, and a binding affinity table.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Spyre Therapeutics
Pitch deck Investor relations Beat · Evidence & Proof2 hits
11
Pharmacokinetic study results showing extended half-life for the drug candidate.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Spyre Therapeutics
Pitch deck Investor relations Beat · Evidence & Proof2 hits
14
Includes PK modeling data comparing human and NHP half-lives and steady-state concentration simulations.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Spyre Therapeutics
Pitch deck Investor relations 2 hits
16
The slide uses a bar chart to show dose-response correlation and a line chart to show pharmacokinetic modeling.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Spyre Therapeutics
Pitch deck Investor relations 2 hits
23
The slide uses two distinct chart types: a scatter plot for binding affinity and a dose-response curve for functional inhibition.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Spyre Therapeutics
Pitch deck Investor relations 2 hits
17
Includes box plots for AUC and Cmax across dose levels (1, 3, 8, 15, 25, 50 mg).Alkermes | Results Presentation Deck | 27 slides · Alkermes
Conference presentation Investor relations Beat · Market Size2 hits
03
The slide includes a footnote explaining the F/X adjusted metric.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · What Is2 hits
04
The slide uses a bar chart for time-series growth and a pie chart for segment composition.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · What Is2 hits
09
TTM = Trailing Twelve MonthsAmazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · What IsLoop · Voice Of Customer2 hits
10
TTM figures provided at the bottom.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · What IsLoop · Voice Of Customer2 hits
11
TTM = Trailing Twelve Months. F/X = Foreign Exchange.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · What IsLoop · Voice Of Customer2 hits
15
The slide uses a combination of stacked bar charts for inflows and grouped bar charts for earnings to demonstrate growth trends.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Beat · SatisfactionLoop · Golden Circle2 hits
16
Includes both actual and normalized net spread bridge charts.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Beat · SatisfactionLoop · Golden Circle2 hits
17
Includes a donut chart for portfolio composition and a bar chart for historical performance.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Beat · SatisfactionLoop · Golden Circle2 hits
15
Data presented at EASL 2022. Shows longitudinal patient data for patients 42, 43, and 48.Arbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Product2 hits
22
Includes two distinct charts: a bar chart showing IFN-y fold increase and a line chart showing tumor volume reduction over time.Arbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations 2 hits
04
The slide uses a donut chart for volume distribution and a stacked bar chart for ASP comparison.Aston Martin Lagonda | Results Presentation Deck | 18 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Need2 hits
10
The slide uses a waterfall chart to reconcile Gross Profit to Adjusted EBITDA, showing the impact of various operating expenses and addbacks.Rent The Runway | Results Presentation Deck | 32 slides · Rent The Runway
Conference presentation Investor relations Beat · Need2 hits
11
The slide uses a waterfall bridge to show cash flow components as a percentage of revenue and absolute dollar amounts.Rent The Runway | Results Presentation Deck | 32 slides · Rent The Runway
Conference presentation Investor relations Beat · Need2 hits